Steris (NYSE: STE) reported Q3 EPS of $2.12, $0.15 better than the analyst estimate of $1.97. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.2 billion.

GUIDANCE:

Steris sees FY2022 EPS of $7.85-$7.95, versus the consensus of $7.73.

For earnings history and earnings-related data on Steris (STE) click here.